![Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial - The Lancet Oncology Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/32deef00-50f8-4998-98e7-ca1ebd25eb04/gr1_lrg.jpg)
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial - The Lancet Oncology
![The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-019-1220-z/MediaObjects/12955_2019_1220_Fig3_HTML.png)
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
![The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders | Journal of Patient-Reported Outcomes | Full Text The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders | Journal of Patient-Reported Outcomes | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41687-020-00219-4/MediaObjects/41687_2020_219_Fig1_HTML.png)
The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders | Journal of Patient-Reported Outcomes | Full Text
![Current Oncology | Free Full-Text | CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada Current Oncology | Free Full-Text | CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada](https://www.mdpi.com/curroncol/curroncol-28-00329/article_deploy/html/images/curroncol-28-00329-g001.png)
Current Oncology | Free Full-Text | CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
![Patient-reported outcomes: A new era in clinical research – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub. Patient-reported outcomes: A new era in clinical research – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.](https://cyberleninka.org/viewer_images/1514543/f/1.png)
Patient-reported outcomes: A new era in clinical research – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
![Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection | Nature Communications Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33826-4/MediaObjects/41467_2022_33826_Fig1_HTML.png)
Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection | Nature Communications
![The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-019-1220-z/MediaObjects/12955_2019_1220_Fig1_HTML.png)
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
![Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01775-6/MediaObjects/41591_2022_1775_Fig1_HTML.png)
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine
![Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res](https://www.picronline.org/articles/2011/2/4/images/PerspectClinRes_2011_2_4_137_86879_b2.jpg)
Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res
Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review | PLOS ONE
![OutcomesFacilitator (PROMs) on Twitter: "Patient reported measures such as Patient Reported Outcome Measures (PROMs) and Patient Reported Experience Measures (PREMs) should become common currency in the assessment of the benefits and risks OutcomesFacilitator (PROMs) on Twitter: "Patient reported measures such as Patient Reported Outcome Measures (PROMs) and Patient Reported Experience Measures (PREMs) should become common currency in the assessment of the benefits and risks](https://pbs.twimg.com/media/E66OJsXUYA8iy03.png)